A multicentric observational single arm study to evaluate the effectiveness of toothpaste containing fluoro calcium phosphosilicate (Biomin) in the long-term relief of dentine hypersensitivity
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20254058Keywords:
Dentin hypersensitivity, Fluoro-calcium phosphosilicate, SCASS, VAS, Desensitizing toothpaste, Long-term managementAbstract
Background: Dentin hypersensitivity (DH) is an acute, transient pain from exposed dentin in response to stimuli not attributable to other dental defects or diseases. Among treatment options, fluoro-calcium phosphosilicate (Biomin) toothpaste has shown promising results in recent studies. The objective was to evaluate the long-term effectiveness, safety, and tolerability of Biomin toothpaste in Indian patients with DH.
Methods: This was a prospective, investigator-initiated, multicenter, single-arm, open-label, observational study. Patients used the investigational toothpaste (Hydent Pro) twice daily for 24 weeks. Endpoints included changes in SCASS, VAS pain scores, DHEQ-15, gingival health and supra-gingival plaque scores. Safety and tolerability were monitored throughout.
Results: A total of 121 patients (male: female, 71:50; mean age, 41.1 years) were enrolled. At week 24 significant (p<00.001) reductions were observed in SCASS (−1.8), VAS (−57.9), DHEQ-15 (−51.3) scores, and both mean Gingival health and supra-gingival-plaque scores also declined significantly (p<0.001) by -1.8, respectively. Investigators rated the effectiveness and tolerability of the toothpaste as excellent to very good in 89.9% and 92.5% patients respectively. No adverse events or other pharmacovigilance relevant information were reported.
Conclusion: Twenty-four weeks of Biomin toothpaste treatment resulted in significant sensitivity relief. Improved overall oral-health-related quality of life; gingival health and anti-plaque action highlight its long-term therapeutic value. Moreover, 24 weeks of treatment with Biomin toothpaste was well-tolerated and can be an effective therapeutic option in the management of DH.
Metrics
References
Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997;24(11):808-13. DOI: https://doi.org/10.1111/j.1600-051X.1997.tb01194.x
Haneet RK, Vandana LK. Prevalence of dentinal hypersensitivity and study of associated factors: a cross-sectional study based on the general dental population of Davangere, Karnataka, India. Int Dent J. 2016;66:49-57. DOI: https://doi.org/10.1111/idj.12206
Mohan S, Thakur J, Verma SK, Jaiswal R, Verma A, Bhagat SK. Prevalence of dentin hypersensitivity in Bihar and Jharkhand- A multicentric study. Univ J Dent Sci. 2021;6:68-73. DOI: https://doi.org/10.21276/ujds.2020.6.3.13
Li R, Yang W, Grimaldi R, Zeng P, Smith G, Chen X. Efficacy of a stannous fluoride dentifrice for relieving dentinal hypersensitivity in Chinese population: an 8-week randomized clinical trial. Clin Oral Investig. 2024;28(4):230. DOI: https://doi.org/10.1007/s00784-024-05610-9
Chan AKY, Tsang YC, Yu OY, Lo ECM, Leung KCM, Chu CH. Clinical evidence for silver diamine fluoride to reduce dentine hypersensitivity: A systematic review. J Dent. 2024;142:104868. DOI: https://doi.org/10.1016/j.jdent.2024.104868
Braennstroem M, astroem A. A study on the mechanism of pain elicited from the dentin. J Dent Res. 1964;43:619-25. DOI: https://doi.org/10.1177/00220345640430041601
Davari A, Ataei E, Assarzadeh H. Dentin hypersensitivity: etiology, diagnosis and treatment; a literature review. J Dent (Shiraz). 2013;14(3):136-45.
Schmidlin PR, Sahrmann P. Current management of dentin hypersensitivity. Clin Oral Investig 2013;17(S1):55-9. DOI: https://doi.org/10.1007/s00784-012-0912-0
Kaimonov MR, Safronova TV. Materials in the Na2O-CaO-SiO2-P2O5 System for Medical Applications. Materials (Basel). 2023;16(17):5981. DOI: https://doi.org/10.3390/ma16175981
Ashwini S, Swatika K, Kamala DN. Comparative Evaluation of Desensitizing Efficacy of Dentifrice Containing 5% Fluoro Calcium Phosphosilicate versus 5% Calcium Sodium Phosphosilicate: A Randomized Controlled Clinical Trial. Contemp Clin Dent. 2018;9(3):330-6. DOI: https://doi.org/10.4103/ccd.ccd_735_17
Patel VR, Shettar L, Thakur S, Gillam D, Kamala DN. A randomised clinical trial on the efficacy of 5% fluorocalcium phosphosilicate‐containing novel bioactive glass toothpaste. J Oral Rehabil. 2019;46(12):1121-6. DOI: https://doi.org/10.1111/joor.12847
Al-Haddad A, Alarami N, Alshammari AF, Madfa AA. Efficacy of bioactive glass-based desensitizer compared to other desensitizing agents or techniques in dentin hypersensitivity: a systematic review. BMC Oral Health. 2025;25(1):899. DOI: https://doi.org/10.1186/s12903-025-06288-5
Schiff T, Delgado E, Zhang YP, Cummins D, DeVizio W, Mateo LR. Clinical evaluation of the efficacy of an in-office desensitizing paste containing 8% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity. Am J Dent. 2009;22:8A-15A.
Baker SR, Gibson BJ, Sufi F, Barlow A, Robinson PG. The Dentine Hypersensitivity Experience Questionnaire: a longitudinal validation study. J Clin Periodontol. 2014;41(1):52-9. DOI: https://doi.org/10.1111/jcpe.12181
Machuca C, Baker SR, Sufi F, Mason S, Barlow A, Robinson PG. Derivation of a short form of the Dentine Hypersensitivity Experience Questionnaire. J Clin Periodontol. 2014;41:46-51. DOI: https://doi.org/10.1111/jcpe.12175
Lobene RR. A Modified Gingival Index for Use in Clinical Trials. Clin Prevent Dent. 1986;8:3.
Tobias G, Spanier AB. Modified Gingival Index (MGI) Classification Using Dental Selfies. Appl Sci. 2020;10:8923. DOI: https://doi.org/10.3390/app10248923
Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of victamine C. J Periodontol. 1970;41:41-3. DOI: https://doi.org/10.1902/jop.1970.41.41.41
Arshad S, Zaidi SJA, Farooqui WA. Comparative efficacy of BioMin-F, Colgate Sensitive Pro-relief and Sensodyne Rapid Action in relieving dentin hypersensitivity: a randomized controlled trial. BMC Oral Health. 2021;21(1). DOI: https://doi.org/10.1186/s12903-021-01864-x
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89:S159-72. DOI: https://doi.org/10.1002/JPER.18-0006